Be the Bridge Between Researchers and a Cure (Hepatitis B, Melanoma, Alzheimer's Disease, Leukemia, and More)

This study is currently recruiting participants.
Verified December 2013 by Sanguine Biosciences
Sponsor:
Information provided by (Responsible Party):
Sanguine Biosciences
ClinicalTrials.gov Identifier:
NCT01931644
First received: August 23, 2013
Last updated: December 11, 2013
Last verified: December 2013
  Purpose

At Sanguine Biosciences, we consider ourselves the bridge between patients like you and researchers striving to find the cure. We collect blood and/or tissue samples and in-depth profiles for medical researchers. Donate from your home, track your sample, and help specialists get the information they need to advance medical research.


Condition
All Diagnosed Health Conditions

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

Resource links provided by NLM:


Further study details as provided by Sanguine Biosciences:

Primary Outcome Measures:
  • Biospecimen & Clinical Data Collection [ Time Frame: 10 years ] [ Designated as safety issue: No ]
    To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results


Biospecimen Retention:   Samples With DNA

Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid, tumor tissue, urine


Estimated Enrollment: 20000
Study Start Date: July 2013
Estimated Study Completion Date: December 2040
Estimated Primary Completion Date: August 2020 (Final data collection date for primary outcome measure)
Groups/Cohorts
Health Condition
Collect blood and other optional biospecimens from participants with a diagnosed health condition
Healthy Control
Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition

Detailed Description:

This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Diagnosed with a health condition

Criteria

Inclusion Criteria:

  • All adults 18-100 years old
  • Able to provide proof of diagnosis
  • Live near Los Angeles, San Francisco, San Diego, New York City, Boston, Washington DC

Exclusion Criteria:

  • Younger than 18 years old
  • Receipt of blood products within 30 days of study blood collection
  • Receipt of investigational drug within 30 days of study blood collection
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01931644

Contacts
Contact: Carlyn Crisostomo, MBA 877-864-3053 donors@sanguinebio.com
Contact: Kendra Hughes, MA 877-864-3053 donors@sanguinebio.com

Locations
United States, California
Sanguine Biosciences Recruiting
Valencia, California, United States, 91355
Contact: Kendra Hughs       donors@sanguinebio.com   
Principal Investigator: Carlyn Crisostomo         
Sub-Investigator: Kristen Warren, MBS         
Sponsors and Collaborators
Sanguine Biosciences
Investigators
Principal Investigator: Carlyn Crisostomo Sanguine Biosciences
  More Information

No publications provided

Responsible Party: Sanguine Biosciences
ClinicalTrials.gov Identifier: NCT01931644     History of Changes
Other Study ID Numbers: SAN-BB-01
Study First Received: August 23, 2013
Last Updated: December 11, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Sanguine Biosciences:
Primary Biliary Cirrhosis
Cancer
Diabetes
Melanoma
Hepatitis B
Lupus
Multiple Sclerosis
Asthma
Crohn's Disease
Ulcerative Colitis
Kidney Disease
Alzheimer's Disease
Parkinson's Disease
Huntington's Disease
Rheumatoid Arthritis
Sjogren's Syndrome
Leukemia
Lymphoma
Myeloma
CIDP
COPD
Idiopathic Thrombocytopenia Purpura
Cystic Fibrosis
Amyloidosis

Additional relevant MeSH terms:
Alzheimer Disease
Hepatitis
Hepatitis B
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Liver Diseases
Digestive System Diseases
Hepadnaviridae Infections
DNA Virus Infections
Virus Diseases
Hepatitis, Viral, Human

ClinicalTrials.gov processed this record on April 17, 2014